Literature DB >> 28460510

[Coexistence of sarcoidosis and primary Sjögren syndrome: a clinical analysis and literature review].

X Y Song1, H Huang, Y Z Liu, Y Y Zhao, S Li, Z J Xu.   

Abstract

Four patients with coexistence of sarcoidosis and primary Sjögren syndrome (pSS) were retrospectively analyzed.All patients were female, who were referred to our department mainly because of respiratory symptoms.Positive antinuclear antibody(ANA) was detected in 2 patients and anti-Sjögrens syndrome A (SSA) antibody positive in 1 patient.All patients presented specific histologic patterns of both sarcoidosis and pSS.Publications related to coexistence of these two diseases were reviewed.Forty-one patients were finally included in the analysis, among whom 37 confirmed patients were from literature search.There were 37 women and 4 men.The main clinical features presentation were xerophthalmia in 40, xerostomia in 38, hilaradenopathies in 28, interstitial lung disease in 15, respiratory symptoms in 13.The main immunologic data were positive ANA in 23, SSA antibody in 19, anti-Sjögrens syndrome B antibody in 10 and rheumatoid factor in 12.All patients presented specific histologic patterns of both diseases.Patients with both sarcoidosis and pSS of ten represent multisystemic involvement and positive immunologic parameters, as well as the dual expression of specific histologic characteristics.

Entities:  

Keywords:  Diagnosis; Sarcoidosis; Sjögrens syndrome

Mesh:

Substances:

Year:  2017        PMID: 28460510     DOI: 10.3760/cma.j.issn.0578-1426.2017.05.014

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  2 in total

1.  Concurrent primary Sjögren's syndrome and isolated ocular sarcoidosis presenting with bilateral corneal scarring and dry eye.

Authors:  David Cui; Tiffany S Liu; Priya M Mathews; Alan N Baer; Esen K Akpek
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-17

2.  Anti-Nuclear Antibodies Patterns in Patients With Systemic Lupus Erythematosus and Their Correlation With Other Diagnostic Immunological Parameters.

Authors:  Jamil A Al-Mughales
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.